CMR Surgical makes Versius, a compact modular surgical robot from Cambridge whose small independent arms fit existing operating theatres; it is used for colorectal, gynaecological and urological cancer operations in Europe, India and elsewhere and received US authorisation in 2024.
Founded in 2014, CMR Surgical designed Versius around small, cart-mounted arms modelled on the human arm so that hospitals could adopt robotics without a dedicated theatre, with an open console and a pay-per-use model to lower the barrier. It has been used in more than a hundred thousand procedures, mainly colorectal, gynaecological, upper gastrointestinal and urological surgery, and gained US marketing authorisation in 2024. OnCo links it to surgical robot platforms and robotic surgery.
Shares Surgical robots: da Vinci, Hugo, Versius and single-port systems, Robotic & minimally invasive surgery and the tag machines-wave.
Shares Prostate cancer and the tag machines-wave.
Shares Prostate cancer, Colorectal cancer and the tag machines-wave.
Shares Endometrial cancer, Prostate cancer and the tag machines-wave.
Shares Surgical robots: da Vinci, Hugo, Versius and single-port systems and the tag machines-wave.
Shares Prostate cancer, Colorectal cancer and the tag machines-wave.
Shares Prostate cancer and the tag machines-wave.
Shares Prostate cancer and the tag machines-wave.